6612 logo

ICARES Medicus, Inc. Stock Price

TPEX:6612 Community·NT$3.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6612 Share Price Performance

NT$70.00
-29.09 (-29.36%)
NT$70.00
-29.09 (-29.36%)
Price NT$70.00

6612 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with very low risk.

2 Risks
0 Rewards

ICARES Medicus, Inc. Key Details

NT$1.1b

Revenue

NT$462.8m

Cost of Revenue

NT$668.2m

Gross Profit

NT$616.9m

Other Expenses

NT$51.2m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
1.08
59.08%
4.53%
39.2%
View Full Analysis

About 6612

Founded
2011
Employees
n/a
CEO
n/a
WebsiteView website
www.icaresmedicus.com

ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, United Kingdom, Japan, Spain, China, Germany, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, farsightedness, presbyopia, or astigmatism, as well as related technical services. In addition, it offers artificial crystal products; and lubricious implantable and invasive high-end nanomedicine material. Further, the company engages in molding, mold design, and development; production of medical devices and electronic plastic products; and distribution of ophthalmic medical equipment. ICARES Medicus, Inc. was incorporated in 2011 and is based in Zhubei, Taiwan.

Recent 6612 News & Updates

Recent updates

No updates